Modulation of Inflammatory and Hemostatic Markers in Obstructive Sleep Apnea Patients Treated with Mandibular Advancement Splints: A Parallel, Controlled Trial
- 15 March 2014
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 10 (3) , 255-262
Abstract
Obstructive sleep apnea (OSA) is associated with systemic inflammation and a hypercoagulable state. The current study aim was to investigate whether mandibular advancement splint (MAS) therapy affects inflammatory and hemostatic parameters in patients with mild-to-moderate OSA. Twenty-two patients with mild-to-moderate OSA and 16 control subjects were studied. OSA subjects were treated with a titratable MAS for 6 months. Baseline plasma C-reactive protein, interleukin-1β, interleukin-10, interleukin-6, P-selectin, fibrinogen, D-dimer, plasminogen activator inhibitor-1 (PAI-1), thrombin-antithrombin complex, activated thrombin-activatable fibrinolysis inhibitor (TAFIa), 6-keto-PGF1α, glucose, and fibrin clot lysis time (CLT) were measured in all subjects. After 3 months of MAS therapy, measurements were repeated for the 22 patients, and after 6 months all measurements were repeated for all study subjects. MAS treatment reduced significantly AHI at 3 months (24 vs 13.1/h) and further improved it at 6 months (13.1 vs 7.05/h). Compared with controls, OSA subjects had a significant higher baseline mean levels of fibrinogen, TAFIa, 6-keto-PGF1α, and glucose. MAS treatment significantly improved levels of IL-1β, D-dimer, TAFIa, and CLT. Despite residual apneas, MAS treatment group presented similar measured homeostatic and inflammatory levels to controls except for glucose. Treatment with MAS in mild-to-moderate OSA subjects improves the inflammatory profile and homeostatic markers. Niżankowska-Jędrzejczyk A; Almeida FR; Lowe AA; Kania A; Nastałek P; Mejza F; Foley JH; Niżankowska-Mogilnicka E; Undas A. Modulation of inflammatory and hemostatic markers in obstructive sleep apnea patients treated with mandibular advancement splints: a parallel, controlled trial.Keywords
This publication has 29 references indexed in Scilit:
- Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseasesJournal of Allergy and Clinical Immunology, 2011
- An orthodontic oral applianceThe Angle Orthodontist, 2010
- Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1Blood, 2010
- The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoeaJournal of Sleep Research, 2009
- Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance – a three‐year follow‐upJournal of Oral Rehabilitation, 2009
- Hypofibrinolysis is a risk factor for arterial thrombosis at young ageBritish Journal of Haematology, 2009
- Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in DelhiSleep Medicine, 2008
- Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesityThorax, 2007
- Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoeaThorax, 2007
- Treatment of snoring and obstructive sleep apnea with mandibular repositioning appliancesSleep Medicine Reviews, 2004